Time to onset of creatine kinase elevation in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study
Publication
, Conference
Farberg, AS; Lewis, K; Kheterpal, M; Gebauer, K; Guminski, A; Loquai, C; Squittieri, N; Gutzmer, R
Published in: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
2021
Duke Scholars
Published In
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
EISSN
1097-6787
ISSN
0190-9622
Publication Date
2021
Volume
85
Issue
3
Start / End Page
AB87 / AB87
Related Subject Headings
- Dermatology & Venereal Diseases
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Farberg, A. S., Lewis, K., Kheterpal, M., Gebauer, K., Guminski, A., Loquai, C., … Gutzmer, R. (2021). Time to onset of creatine kinase elevation in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study. In JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (Vol. 85, pp. AB87–AB87).
Farberg, Aaron S., Karl Lewis, Meenal Kheterpal, Kurt Gebauer, Alexander Guminski, Carmen Loquai, Nicholas Squittieri, and Ralf Gutzmer. “Time to onset of creatine kinase elevation in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study.” In JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 85:AB87–AB87, 2021.
Farberg AS, Lewis K, Kheterpal M, Gebauer K, Guminski A, Loquai C, et al. Time to onset of creatine kinase elevation in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study. In: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2021. p. AB87–AB87.
Farberg, Aaron S., et al. “Time to onset of creatine kinase elevation in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study.” JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, vol. 85, no. 3, 2021, pp. AB87–AB87.
Farberg AS, Lewis K, Kheterpal M, Gebauer K, Guminski A, Loquai C, Squittieri N, Gutzmer R. Time to onset of creatine kinase elevation in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2021. p. AB87–AB87.
Published In
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
EISSN
1097-6787
ISSN
0190-9622
Publication Date
2021
Volume
85
Issue
3
Start / End Page
AB87 / AB87
Related Subject Headings
- Dermatology & Venereal Diseases
- 3202 Clinical sciences
- 1103 Clinical Sciences